Observational studyPloS one2025
Cardiovascular and renal comorbidities among saudi patients with type 2 diabetes: A cross-sectional observational study.
Observational study in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Saudi Clinical Practice Guidelines for management of diabetic kidney disease in adults.Saudi medical journal · 2025Guideline
- Microneedle Strategies for Diabetic Wound Management: A Comprehensive Review of Materials, Mechanisms, and Therapeutic Outcomes.Materials today. Advances · 2026Article
- Descriptive analysis of hypertension in Saudi Arabia: a national population health perspective (hypertension in Saudi Arabia).Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aims to investigate the prevalence and patterns of cardiovascular and renal complications among patients with T2DM in the Saudi population and elucidate the extent of these comorbidities and their potential risk factors.
methodsA cross-sectional observational study was conducted across three research locations in Riyadh, Saudi Arabia. The study incorporated the first 248 T2DM patients who met the criteria and provided their consent. The sites for this research comprised one secondary care public hospital, one public primary care clinic, and one private medical facility. Efforts were made to evenly distribute patients across the six locations, spanning three distinct sectors. Should any location fall short of its patient target, other sites would step in to balance the deficit. Patient data was gathered during their enrollment visit as well as the patient's medical records. These encompassed variables such as age, gender, race, smoking status, residential location, duration of T2DM, most recent HbA1c, blood pressure, lipid levels, kidney function, and most recent weight/body mass index (BMI).
resultsThose with diabetes for five years or longer were more likely to have CKD (2.1 times higher), CAD (3.2 times higher), cerebrovascular disease (4.3 times higher), and hypertension (6.2 times higher). Most participants knew diabetes was a common health problem, and those with diabetic relatives were at a higher risk. In the present study, patients with uncontrolled HbA1C diabetes demonstrated a notably increased prevalence of various comorbidities CKD (OR=3.9, p < 0.0001), CAD (OR=2.3, p = 0.007), CHF (OR=3.1, p = 0.0001), cerebrovascular disease (OR=2.4, p = 0.0004), CVD (OR=4.2, p=<0.0001) and hypertension (OR=3.5, p = 0.0001) compared to those without uncontrolled HbA1C diabetes. However, CVD and hypertension shows a stronger association with diabetes The analysis demonstrated that diabetes was highly correlated to neuropathy (t = 2.204, p = 0.002), coronary artery disease (t = 1.53, p = 0.03), congestive heart failure (CHF) (t = 1.34, p = 0.05), cerebrovascular Disease (t = 2.65, p = 0.009), and hypertension (t = 5.05, p = 0.000).
conclusionWe concluded that patients who had diabetes for five years or more had considerably greater risks of developing comorbidities such as chronic kidney disease, coronary artery disease, cerebrovascular disease, and hypertension. Among others hypertension being a major comorbidity that significantly influences the progression or presence of diabetes. This highlights the necessity of beginning treatment as early as possible and maintaining glycemic control to reduce the risk of diabetes-related problems in the long run. One limitation of this study is its cross-sectional design, which only captures data at a single point in time, preventing the establishment of causal relationships between variables.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.